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Sorting of ubiquitinated membrane proteins into
lumenal vesicles ofmultivesicular bodies ismediated
by the Endosomal Sorting Complex Required for
Transport (ESCRT) apparatus and accessory pro-
teins such as Bro1, which recruits the deubiquitinat-
ing enzyme Doa4 to remove ubiquitin from cargo.
Here we propose that Bro1 works as a receptor for
the selective sorting of ubiquitinated cargos. We
found synthetic genetic interactions between BRO1
and ESCRT-0, suggesting that Bro1 functions simi-
larly to ESCRT-0. Multiple structural approaches
demonstrated that Bro1 binds ubiquitin via the N-ter-
minal trihelical arm of itsmiddle V domain.Mutants of
Bro1 that lack the ability to bind Ubwere dramatically
impaired in their ability to sort Ub-cargo membrane
proteins, but only when combined with hypomorphic
alleles of ESCRT-0. These data suggest that Bro1
and other Bro1 family members function in parallel
with ESCRT-0 to recognize and sort Ub-cargos.
INTRODUCTION
Ubiquitin (Ub) is a sorting determinant mediating the degradation
of a wide variety of membrane proteins in lysosomes by sorting
them into the intralumenal vesicles (ILVs) of multivesicular
endosomes/bodies (MVBs) (Hanson and Cashikar, 2012). Ub
is recognized by the ESCRT (Endosomal Sorting Complex
Required for Transport) apparatus, which couples cargo recog-
nition and sorting with the formation and scission of intralumenal
vesicles (Henne et al., 2011). Recognition of ubiquitinated cargo
(Ub-cargo) occurs early during ILV formation and is mediated in
large part by ESCRT-0 and ESCRT-I, which each have multiple
Ub-binding domains (UBDs) (Clague et al., 2012; Shields and
Piper, 2011). ESCRT-0, composed of Vps27 and Hse1 in yeast
and by Hrs and STAM1/2 in humans, binds Ub via multiple
UBDs housed within its Vps27/Hrs/Stam (VHS) and Ubiquitin520 Developmental Cell 25, 520–533, June 10, 2013 ª2013 Elsevier IInteractingMotif domains. ESCRT-0 is thought to be the endoso-
mal Ub-sorting receptor that initiates cargo capture and has
a variety of protein interactions that equip it for this task. Direct
binding to clathrin positions it within clathrin-enriched
endosomal subdomains where cargo is segregated for recycling
or degradation. ESCRT-0 also binds ESCRT-I to facilitate
assembly of the ESCRT apparatus and the transfer of Ub-cargo
to ESCRT-I and -II. ESCRT-0 also associates with both Ub
ligases and deubiquitinating enzymes (DUbs) that may alter
cargo ubiquitination and regulate its sorting into the MVB
pathway. Several other proteins are proposed to work in parallel
to ESCRT-0 as alternative ESCRT-0-like Ub-sorting receptors
(Clague et al., 2012; Shields and Piper, 2011). Among these
are the Tom1:Tollip complex and GGA3. Like the two subunits
of ESCRT-0, both Tom1 and GGA3 have VHS domains and
bind clathrin, ESCRT-I, and Ub. Functional studies implicate
these as endosomal Ub-sorting receptors, although their site(s)
of action and the repertoire of cargo substrates have yet to be
clarified.
Late in the sorting process, ILVs are separated from the
limiting membrane of the endosome by ESCRT-III, a heteropoly-
meric assembly of subunits centered on Snf7/CHMP4 (Babst
et al., 2011). Yeast Snf7 also binds to Bro1, which in turn recruits
the DUbDoa4 to remove Ub from cargo prior to its entry into ILVs
(Kim et al., 2005; Luhtala andOdorizzi, 2004; Richter et al., 2007).
Loss of Doa4 causes Ub to hyperaccumulate in the vacuole
lumen and be depleted from the cytosol (Amerik et al., 2000;
Ren et al., 2008). The Bro1:Doa4 complex is thought to work
late in the sorting process, since earlier removal of Ub would
permit cargo to escape incorporation into ILVs. However, loss
of Bro1 produces a phenotype similar to loss of ESCRTs, while
loss of Doa4 does not, demonstrating that Bro1 provides func-
tions beyond the recruitment of Doa4 (Odorizzi et al., 2003;
Raymond et al., 1992; Springael et al., 2002). Bro1 belongs to
a larger family of related proteins, including mammalian Alix
and HD-PTP, which share a common architecture, bind
ESCRT-I, and have both an N-terminal Bro1 homology domain
that binds the ESCRT-III subunit Snf7/CHMP4 and a middle V
domain that, in the case of Alix, binds YPxL peptide motifs
(Fisher et al., 2007; Kim et al., 2005; Lee et al., 2007). YPxL bind-
ing enables Alix to sort YPxL-bearing cargos into MVBs and tonc.
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proteins bearing YPxL motifs (Baietti et al., 2012; Dores et al.,
2012; Doyotte et al., 2008; Odorizzi, 2006; Sadoul, 2006; Strack
et al., 2003). These data suggest that Alix and other Bro1-family
proteins might recruit cargo to the ESCRT apparatus, at least
along a Ub-independent pathway. Although a clear role for these
proteins in the canonical sorting of Ub-cargo has not been estab-
lished, recent studies have demonstrated that Alix can bind Ub,
thus supporting this possibility (Joshi et al., 2008; Keren-Kaplan
et al., 2013; Sangsuriya et al., 2010; Dowlatshahi et al., 2012).
Here we propose that Bro1works in parallel with ESCRT-0 and
contributes to the recognition and sorting of Ub-cargo into the
MVB pathway. We show that deficiencies in Bro1 and ESCRT-0
yield synthetic phenotypes and that, like ESCRT-0, Bro1 binds
clathrin. We show that the V domains of multiple Bro1 family
members bind Ub and that mutations compromising Ub binding
result in defective sorting of Ub-cargo.
RESULTS
Bro1 and the ESCRT-0 Ub-Sorting Receptor Interact
Genetically
Deletion of either Vps27 or Hse1, two ESCRT-0 subunits (orthol-
ogous to Hrs and Stam1/2 in mammalian cells), causes a strong
‘‘class E’’ Vps phenotype characterized by secretion of vacuolar
proteases, accumulation of large late endosomal structures, and
the inability to sort ubiquitinated membrane proteins into the
vacuolar lumen via the MVB pathway (Bilodeau et al., 2002).
This phenotype is observed when HSE1 is deleted from the
SF838-9D parental strain but not when deleted from the
SEY6210 parental strain (Figure 1A), as also noted in previous
studies (Stringer and Piper, 2011). Diploid cells generated from
these two hse1D strains also showed no sorting defects,
providing uswith a genetic tool for identifying genes that function
in parallel with ESCRT-0 and whose depletion exacerbates the
consequences of HSE1 loss. The homozygous hse1D diploid
was sporulated, and after one backcross to SEY6210 hse1D
cells, we found that the phenotype of defective MVB sorting
segregated 2:2 (Figure S1A available online). We determined
the genomic sequence of the SEY6210 hse1D strain and
compared it to that of hse1D segregants from a second and third
backcross that showed MVB sorting defects to identify a single
base-pair change in BRO1 (resulting in a C359Y change) that
was present in defective progeny but not in the parental
SEY6210 hse1D strain. Sanger sequencing confirmed this differ-
ence (Figure 1B).
Residue 359 of Bro1 lies within the linker region between the
N-terminal Bro1 homology domain and the middle V domain.
Importantly, the SF838-9D parental strain has normal MVB and
vacuolar protease sorting pathways despite having the BRO1
Y359 allele. However, a bro1D deletion has a typical ‘‘class E’’
Vps phenotype (Raymond et al., 1992), indicating that a sorting
defect results only when the Y359-encoding allele of BRO1 is
combinedwith loss ofHSE1. As confirmation, wemade homozy-
gous hse1D diploids from SF838-9D and SEY6210, in which the
BRO1 genewas knocked out of either haplotype. The hse1D dip-
loids having only the Y359 Bro1 from SF838-9D showed a strong
MVB sorting defect as assessed by the localization of Sna3-GFP
(Figure 1C), a well-characterized MVB cargo (Macdonald et al.,Devel2012b). In contrast, hse1D homozygotes with the SEY6210 allele
of BRO1 (C359) sorted Sna3-GFP normally. Although the
biochemical defects of the Y359 Bro1 mutant were not investi-
gated, the value of this mutant was to help uncover the genetic
interaction between Bro1 and ESCRT-0.
To confirm the synthetic genetic interaction between Bro1 and
Hse1, we analyzedMVB sorting in SEY6210 bro1D cells that also
contained defined mutations in ESCRT-0 (Figure 1D). Loss of
Bro1 blocked the delivery of Ste3-GFP to the vacuole lumen,
causing these cells to accumulate large ‘‘class E’’ endosomal
compartments. Interestingly, other cargoes could still be sorted
to the vacuole of bro1D cells, albeit to a limited degree. Both
Ste3-GFP-Ub (an in-fame fusion of Ub on to Ste3-GFP) and
GFP-tagged Mup1 (a methionine transporter) were sorted
moderately well in bro1D cells and normally in hse1D cells.
Combined loss of HSE1 and BRO1 caused substantial sorting
defects that were observed by microscopy (Figure 1D) and by
immunoblotting for a GFP fragment (Figure S1B), which is
cleaved from cargo upon delivery into the vacuolar lumen (Het-
tema et al., 2004). A synthetic defect was also observed when
the bro1Dmutation was combined with a hypomorphic mutation
in Vps27 that blocks the ability of ESCRT-0 to bind to clathrin
(vps27Dchc1) (Bilodeau et al., 2003; Shields et al., 2009). Finally,
we found that levels of Bro1 were unperturbed by alterations
in ESCRT-0 and that levels of ESCRT-0 subunit Vps27 were
unperturbed by changes in BRO1 or HSE1, indicating that the
synthetic interaction between Bro1 and ESCRT-0 functions is
specific (Figure S1C).
Bro1 Acts Early in Cargo Sorting and Binds Clathrin
The synthetic genetic interaction between Bro1 and ESCRT-0
suggested that Bro1 may act early in the MVB sorting process
in parallel with ESCRT-0. This function would be distinct from
that previously established for Bro1, which is to recruit the
Doa4 DUb to ESCRT-III to remove Ub from MVB cargo and
rescue Ub from excessive vacuolar degradation and which is
mediated by Bro1 binding to Snf7 via its N-terminal Bro1 domain
and Doa4 via its proline-rich C-terminal domain (Amerik et al.,
2006; Nikko and Andre´, 2007; Richter et al., 2007). Previous
studies show that fusing the catalytic domain of a DUb onto
ESCRT-0 effectively deubiquitinates cargo ‘‘early’’ in the sorting
process, thereby blocking delivery to the vacuolar lumen
(MacDonald et al., 2012a; Stringer and Piper, 2011). This block
can be circumvented by translationally fusing Ub to the C termini
of cargo, making it resistant to the effects of ESCRT-DUb
fusions. We reasoned that if Bro1 also could intervene early in
the sorting process in parallel to ESCRT-0, then a Bro1-DUb
fusion protein should also block cargo sorting to the vacuole
and not merely replace the Bro1:Doa4 complex thought to
work postsorting to simply recycle Ub. Fusions of Bro1 to the
catalytic domain of Ubp7 or UL36 (a yeast cysteine-based Ub-
specific protease or a DUb found within the tegument protein
of herpes simplex virus-1, respectively) were expressed in
wild-type cells (Figure 2A). In addition to causing defective sort-
ing of Ste3 and Sna3, Bro1-Ubp7 and Bro1-UL36 also perturbed
sorting of Gap1 and Fur4 (the general amino acid permease and
uracil permease). In contrast, Ste3-GFP-Ub, containing an in-
frame fusion of Ub that cannot be removed by DUbs, sorted nor-
mally, demonstrating that Bro1-Ubp7 and Bro1-UL36 exert theiropmental Cell 25, 520–533, June 10, 2013 ª2013 Elsevier Inc. 521
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Figure 1. Synthetic Interaction between
Bro1 and ESCRT-0
(A) Localization of Sna3-GFP in hse1D null mutants
generated from the SEY6210 and SF838-9D
parental strains. Shown are differential interfer-
ence contrast (DIC) andGFP fluorescence images.
(B) Chromatograms of BRO1 open reading frame
sequence (Sanger sequencing of PCR-amplified
DNA) from SEY6210 cells (top) or SF838-9D cells
(bottom). Arrowhead in schematic below indicates
location of residue 359 between the N-terminal
Bro1 homology domain (B1D) and the middle V
domain.
(C) Demonstration that the bro1 Y359 allele causes
a synthetic phenotype with hse1D. BRO1 was
disrupted in MAT(A) SEY6210 hse1D or MATa
SF838 hse1D haploids, and these were subse-
quently mated to form diploids. Sorting of Sna3-
GFP to the vacuole lumen was defective in hse1D
homozygous diploids with only the bro1Y359 allele
from the SF838-9D haplotype. However, Sna3-
GFP was correctly sorted in hse1D homozygous
diploids with only BRO1C359 from the SEY6210
haplotype. Diploids heterozygous for both hse1D
bro1D also sorted Sna3-GFP properly regardless
of either haplotype.
(D) Localization of Ste3-GFP, Ste3-GFP-Ub, and
Mup1-GFP in SEY6210 cells of the indicated
genotypes: WT; bro1D null alone; bro1D hse1D
double null; Vps27 lacking its C-terminal clathrin-
binding motif (vps27DChc1); hse1D alone or the
vps27DChc1 mutation alone. Scale bar, 5 mM.
See also Figure S1 and Tables S1 and S2.
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Bro1 as a Ubiquitin-Sorting Receptorinhibitory effect at the level of deubiquitinating cargo rather than
altering the function of ESCRT apparatus itself. Mup1-GFP was
only modestly affected by the Bro1-DUb fusions (Figure 2A) and
also underwent some level of MVB sorting, even in the absence522 Developmental Cell 25, 520–533, June 10, 2013 ª2013 Elsevier Inc.of Bro1 (Figure 1D), suggesting that Bro1
may normally operate on a subset of MVB
cargos.
The effect of Bro1-DUb in blocking
cargo sorting is not due simply to recruit-
ing DUb activity to ESCRT-III. We
found that expressing a fusion of UL36
to the Microtubule Interacting and Traf-
ficking (MIT) domain of Vps4, which inter-
acts with MIT-Interaction Motifs within
ESCRT-III subunits (Obita et al., 2007;
Stuchell-Brereton et al., 2007), did not
affect MVB cargo sorting (Figure 2B).
However, MIT-UL36 as well as UL36
fusion to full-length Bro1 and just the
N-terminal Bro1 domain prevented the
delivery of GFP-Ub into the vacuole,
demonstrating that these proteins could
stimulate recycling of Ub from cargo
before it was consumed in the MVB
sorting process. Thus, the dominant
effect of Bro1-DUb proteins on the sort-
ing of particular cargos likely reflects afunction of Bro1 that works early in the cargo sorting process
(Figure 2C).
One of the biochemical features of ESCRT-0 and other pro-
posed ESCRT-0-like Ub-sorting receptors such as Tom1 and
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Figure 2. Effect of Bro1-DUb Fusion Protein on the Sorting of MVB Cargo
(A) Bro1 fusion proteins containing the catalytic domain of either Ubp7 (Bro1-Ubp7) or UL36 (Bro1-UL36) were expressed from the copper-inducible CUP1
promoter in WT cells, in combination with the indicated GFP-tagged MVB cargo proteins. Shown are DIC and GFP fluorescence images.
(B) Left: sorting of GFP-Ub in WT cells or in cells expressing the UL36 fused to His3 (His3-UL36), the N-terminal MIT domain of Vps4 (MIT-UL36), the N-terminal
Bro1 domain (B1D-UL36), or full-length Bro1 (Bro1-UL36) (left). WT cells or cells expressing a His3-UL36 fusion protein accumulate some GFP-Ub within
vacuoles. Expression of Bro1-UL36 or MIT-UL36 excludes GFP-Ub from vacuoles. Right: MIT-UL36 was also coexpressed in WT cells with the indicated GFP-
tagged MVB cargo. Scale bar, 5 mM
(C) Model for how Bro1 might work in two places: early in the process of cargo sorting in conjunction with ESCRT-0, such that the Bro1-DUb fusion proteins
deubiquitinate cargo and block subsequent sorting into the MVB pathway; and late in the sorting process in conjunction with ESCRT-III, to recycle Ub from the
MVB pathway and thus prevent its accumulation in the vacuole. This latter function can be mimicked by MIT-DUb.
(legend continued on next page)
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Bro1 as a Ubiquitin-Sorting ReceptorGGAs is that they bind clathrin, which is found in distinct endo-
somal subdomains that concentrate Ub-cargo and help localize
ESCRT-0 (Shields and Piper, 2011). Coimmunoprecipitation
experiments showed that Bro1 shares the ability of ESCRT-0
to associate with clathrin in vivo (Figure 2D). Clathrin-binding
activity was housed within the middle Bro1 V domain since a
glutathione S-transferase (GST)-V domain fusion protein was
sufficient to pull down clathrin from yeast lysates (Figure 2E).
Also, the recombinant N-terminal b-propeller domain of clathrin
heavy chain could specifically bind GST-V, indicating that the
Bro1 V domain binds directly to clathrin (Figure 2E). Interestingly,
Bro1 has a conserved clathrin binding box motif (ter Haar et al.,
2000) within an unstructured loop at the vertex of its V domain
(Figures S2A and S2B). However, mutations in this region did
not block coimmunoprecipitation of Bro1 with clathrin from cell
lysates, suggesting that other motifs may also be sufficient for
clathrin association (data not shown).
The V Domains of Bro1 Family Proteins Bind Ub
One of the key features of ESCRT-0 that allows it to act as a sort-
ing receptor for Ub-cargo is its ability to bind Ub. Recently, the
Bro1 homolog Alix was found to bind Ub via its middle V domain
(Joshi et al., 2008). The Alix V domain is organized into two trihel-
ical bundles adopting the shape of a V with a short and long arm
(Fisher et al., 2007; Lee et al., 2007).We found that the V domains
of Bro1, Rim20, human Alix, and HD-PTP bind directly to Ub
even though they share only a moderate level of sequence iden-
tity. This was demonstrated by the ability of recombinant V
domains to bind a Ub-GST fusion protein (Figure 3A) and to
bind K63-linked polyubiquitin (poly-Ub) chains (Figure 3B).
Chemical shift perturbations measured by nuclear magnetic
resonance (NMR) heteronuclear single quantum coherence
(HSQC) experiments with 15N-Ub showed that the Bro1 V
domain bound mono-Ub (Figures 3C, S3A, and S3B) and used
a binding surface centered on the hydrophobic patch of Ub
that comprised I44, V70, L8, and R42 (Figure 3D), which serves
as a common surface engaged by the vast majority of Ub-bind-
ing proteins (Husnjak and Dikic, 2012). These experiments
utilized the V domain from S. castelli Bro1, which shares 56%
identity with S. cerevisiae Bro1 V but had better stability
in vitro. The Alix V domain also bound mono-Ub through the
same general surface patch, although the profile of chemical
shift perturbations in 15N-Ub induced by Alix V binding was
slightly different, indicating a different binding mode (Figure 3D;
Figures S3A and S3B). Significant line broadening was evident
for all peaks of 15N-Ub with increasing concentrations of V
domains (Figure S3C). This wasmost severe for His-domain pro-
tein tyrosine phosphatase (HD-PTP) V domain, which precluded
the ability to use chemical shift changes to map the interface on
Ub. The NMR peaks from Ub bound to V domain were likely
broadened because the Ub-V complex is much larger than Ub
alone and in range of intermediate exchange on the NMR time-(D) Immunoprecipitation of HA-tagged Bro1 from spheroplasts prepared from cell
immunoblotted with monoclonal antibodies against Chc1 (top) or HA (bottom).
(E) Pull-down of GST alone (GST-ø) or GST fused to the Bro1 V domain (GST-V). Be
pull-down of Chc1 from yeast lysates. Bottom: pull-down of a monomeric 6xHis-
version containing a trimerization domain (HISChcN3).
See also Figure S2 and Tables S1 and S2.
524 Developmental Cell 25, 520–533, June 10, 2013 ª2013 Elsevier Iscale. Using loss of peak intensity as a measure of binding esti-
mates the dissociation constant, KD, of the V domains of Alix and
HD-PTP in the range of50 mMand the S. castelliBro1 V domain
5 times higher.
To map the major Ub-binding site on Bro1 V in solution, we
performed a series of paramagnetic relaxation enhancement
(PRE) experiments using a set of Bro1 V mutants containing a
nitroxide spin label (methanethiosulfonate [MTSL]) attached to
cysteine residues substituted at different positions (Figure 3E).
MTSL-labeled Bro1 V proteins were used in HSQC experiments
with 15N-Ub in the presence and absence of ascorbate. The
oxidized form of the attached MTSL enhances the relaxation
rate of nearby spin systems, resulting in a loss of peak intensity
in HSQC spectra as compared to the ascorbate-reduced form
that has lost its unpaired electron (Iwahara and Clore, 2006). Sig-
nificant PRE effects on any of the residues of 15N-Ub were
plotted for each of the labeled Bro1 V variants (Figure 3F),
revealing dramatic effects for spin labels incorporated in the
N-terminal helix of first trihelical arm of the Bro1 V domain at res-
idues 381 and 392. As confirmation, we generated a ‘‘half-V’’
protein that comprised only the first trihelical arm and found
that it bound Ub in GST pull-down assays and induced a profile
of chemical shift perturbations on the surface 15N-Ub similar to
that of full-length Bro1 V (Figures S3D–S3I).
Further structural information about Ub binding was obtained
through protein crystallography experiments yielding a structure
of Ub bound to the first trihelical arm the S. castelli Bro1 V
domain. This structure was solved from crystals containing a
selenomethionine-labeled Bro1V:Ub A28M complex diffracting
to 3.6 A˚ that allowed us to use the single-wavelength anomalous
dispersion method to obtain experimental phases (Table 1). Two
V domains were found in the asymmetric unit with five selenium
sites per molecule of V domain. Despite the low level of
sequence homology, the Bro1 V domain was remarkably similar
to the Alix V domain, each with two trihelical arms with the pro-
tein sequence crisscrossing between the two arms. Unlike Alix
V, the two arms of Bro1 V were of similar size (Figure 4A), and
the relative orientation of the trihelical arms and the helices within
the distal C-terminal arm as they twist through the arm were
different.
Ub was bound to one of the V domains (Chain A) within the
asymmetric unit (Figures 4B, S4A, and S4B), where it was posi-
tioned along residues 375–386 of the exposed inner surface of
the N-terminal trihelical bundle, in direct agreement with the
PRE experiments placing residue 381 near the major site of Ub
binding in solution. Ub was oriented along the N-terminal V
domain helix so that the C terminus of Ub was near the opening
of the V domain and the N terminus of Ub was pointing toward
the vertex of the V domain. The binding surface in Ub that
was identified by chemical shift perturbations in NMR HSQC
experiments (including residues L8, I44, and V70) was oriented
toward the Bro1 V N-terminal helix (Figure 4B). To confirm thes transformed with vector alone or plasmid expressing Bro1-HA. Samples were
ad-bound fractions were immunoblotted as was a 5%equivalent of input. Top:
tagged recombinant N-terminal clathrin b-propeller (HISChcN) or an oligomeric
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Figure 3. V Domains of Bro1 and Other Family Members Bind Ub
(A) GST pull-down experiments of recombinant Bro1 and Rim20 V domains S. castelli, P. pastoris, S. pombe, and S. micatae using GST alone (GST-ø), GST fused
to Ub (Ub), or a mutant Ub with mutations in L8, I44, R42, and V70 (ub*).
(B) Recombinant V domains were immobilized on a-V5 polyclonal antibody-coated beads, washed, and incubated with K63-linked polyubiquitin chains. Beads,
alone or bound to an irrelevant V5-epitope-tagged protein, were also included. Beadswerewashed and immunoblottedwith a-V5 or a-Ubmonoclonal antibodies.
(legend continued on next page)
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labeled Bro1 V domain with MTSL attached to the first residue
of the V domain (residue 369) and compared its PRE profile on
15N-Ub to a Bro1 V domain spin labeled at residue 392. The dif-
ferential PRE effect between these two site-specific spin labels
on the backbone amides of Ub showed that residue 369 of
Bro1 V was nearer to the C terminus of Ub, while 381 was nearer
to the N-terminal region of Ub (Figure S4C). Together, these
data demonstrate that Ub lies along the first alpha helix of the
Bro1 V domain in an antiparallel orientation and indicate that
I377 likely participates in hydrophobic interactions with L8, I44,
and V70 of Ub.
V Domains Adopt an Open Conformation in Solution
The structure of Bro1 V (Figure 4) and previous structures of Alix
V domains show a relatively closed conformation that might
restrict access of some YPxL-containing proteins or ubiquiti-
nated proteins to their binding sites on the inner surface (Fisher
et al., 2007; Lee et al., 2007). Indeed, full-length Alix forms an
intramolecular interaction (between its C-terminal proline-rich
domain and its N-terminal Bro1 homology domain), which dimin-
ishes binding to YPxL-containing proteins. This interaction may
function as a clasp, holding the V domain in a closed conforma-
tion that, upon release, allows the V domain to spring open to
expose protein interaction sites (Pires et al., 2009; Zhai et al.,
2011; Zhou et al., 2010). We obtained several lines of evidence
demonstrating that, in the absence of such a clasp, the V domain
adopts an open conformation in solution. Small angle X-ray scat-
tering (SAXS) data from monodisperse Bro1 and Alix V domains
were used to generate ab initio envelopes and revealed elon-
gated V domains that were splayed open relative to their crystal
structures (Figures 5A and S5A). These elongated shapes were
consistent with gel filtration data and dynamic light scattering,
showing that the monomeric 40 kDa Alix V and the 36 kDa of
Bro1 V domains behaved as larger forms (Figures S5C–S5E).
Attempts to crystallize Alix V in complex with Ub yielded a
6.5 A˚ crystal structure of Alix V in an open conformation without
clear electron density for Ub (Figure 5C; Table 1). The single
wavelength anomalous dispersion technique with isomorphous
crystals of seleniomethionine-labeled Alix V allowed us to locate
the selenium sites, determine phases, and obtain traceable elec-
tron density maps. The features in the electron density maps
clearly matched details in other Alix V structures; however, the
angle between the two arms of Alix V was far greater (e.g., an
open conformation) than that found for the previously deter-
mined closed conformations (Figure 5D; Movie S1). Having
both the open and closed crystal structures of Alix V and the
closed structure of Bro1 V allowed us to calculate experimental(C) HSQC NMR spectra of indicated backbone amides of 30 mM 15N-Ub in the a
(D) Significant chemical shift perturbations [>1 SD of (0.2N2 + H2)1/2] caused by bin
onto themolecular surface of Ub. Shown are front and back views of Ub, with the b
perturbation profiles is shown as yellow in the merge.
(E) Schematic of the S. castelli V domain, which forms two trihelical arms. The am
site-specific spin labels using MTSL.
(F) Summary of paramagnetic relaxation experiments using the series of Bro1 cys
HSQC spectra of 30 mM 15N-Ub with 100 mM of the indicated MTSL-labeled Bro1
2mM ascorbate. Peak intensity ratios of these two spectra were calculated for eac
reflected by a significant reduction in peak intensity ratio, are defined as >1 SD a
See also Figure S3 and Table S1.
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analysis (Figure S5B) showed that the SAXS data best describe
a mix of V domains in both open and closed forms at a ratio of
roughly 50:50.
The large shape changes displayed by V domains prompted
us to test whether they might undergo more dramatic changes
in solution involving the swapping of N- and C-terminal helices
between the trihelical bundles. We engineered a tobacco etch
virus (TEV) protease site in the middle hinge region of the V
domain so that, if a swap did occur, the protein could separate
into two roughly equal fragments. However, cleaved Bro1 V
stayed intact assessed by gel filtration even after extended incu-
bation at 25C (Figure S5F).
Together, these data show that, while the overall topology of V
domains is retained in solution, they can undergo a variety of
conformational changes, with small-scale changes evident in
the packing of the helices within Bro1 V crystals (Figure S4A)
and large-scale changes in a mix of open and closed forms in
solution (Figure 5).
Ub Binding by Bro1 Is Required for MVB Sorting of
Ub-Cargo
To test the functional relevance of Ub binding by Bro1, we gener-
ated mutants of Bro1 V domain specifically defective in binding
Ub. A series of mutations within the first trihelical arm were
tested for their ability to disrupt Ub binding using PRE experi-
ments with 15N-Ub and Bro1 V mutants spin labeled at position
381. Although side chains cannot be resolved with the diffraction
data in the crystal structure, I377 is predicted from our structural
data to be centered under the hydrophobic patch of Ub, whereas
L386 lies under a loop region between a2 and b5 of Ub contain-
ing residues Q62, K63, E64, and S65. We found that mutation of
I377 and/or L386 blocked Ub binding as observed by the loss of
PRE effect in 15N Ub (Figure 6A). Loss of Ub binding was also
indicated by a loss in chemical shift perturbations in the back-
bone amides of Ub residues that mediate binding to Bro1 V (Fig-
ure 6B) and by loss of the ability of Bro1 V domains immobilized
on beads to bind K63 poly-Ub chains (Figure 6C). Compared to
the wild-type (WT) Bro1 V protein, the mutant V domains were
produced at similar levels, were just as soluble, and had identical
NMR proton spectra (Figure S6), indicating that the mutant V
domains retained their overall structure.
We next assessed the ability of Bro1 containing Ub-binding-
defective V domains to sort cargo into the MVB pathway (Fig-
ure 7). Here we analyzed chimeric Bro1 proteins in which the V
domain of a hemagglutinin (HA)-epitope-tagged Bro1 from
S. cerevisiae was substituted with the mutant V domains of
S. castelli characterized earlier. The WT chimeric Bro1-HA wasbsence and presence of the S. castelli V domain at the designated ratios.
ding of the Bro1 or Alix V domain to 15N-Ub in HSQC experiments weremapped
inding surface for Bro1 in green and Alix in red. Overlap in the two chemical shift
ino acid positions in yellow designate cysteine substitutions used to conjugate
teine mutants that bear spin label at the indicated positions. The NMR 15N/1H
V domains were collected in the presence (oxidized) and absence (reduced) of
h backbone amide. Plot of Ub residues that were subject to significant PRE, as
bove the mean for that residue across the whole data set.
nc.
Table 1. Crystallography Statistics
Statistics
SeMet Bro1VSEM:
UbA28M SeMet AlixV:Ub
Data Collection
Space group P212121 I23
Unit cell parameters (A˚) a = 63.43,
b = 92.32,
c = 229.45
a = b = c = 223.77
Resolution (A˚) 34.49–3.50
(3.62–3.50)
39.56–6.50
(6.73–6.50)
Rmerge 8.4 (61.1) 6.1 (74.8)
Unique reflections 17,664 (1,700) 3,774 (370)
< I/s(I) > 6.6 (1.7) 23.3 (2.1)
Completeness (%) 100.0 (99.9) 100.0 (100.0)
Multiplicity 7.1 (7.3) 21.4 (22.3)
Anomalous < I/s(I) > 5.3 (1.0) 18.6 (1.2)
Anomalous completeness (%) 99.9 (99.9) 100.0 (100.0)
Anomalous multiplicity 3.85 (3.83) 11.4 (11.6)
Refinement
Resolution (A˚) 34.49–3.60 39.56–6.50
Number of reflections 16,053 3,760
Rwork/Rfree 36.6/42.1 20.3/28.3
Number of protein atoms 3,536 5,398
B Factors
Wilson (A˚2) 131.3 468.9
Average (A˚2) 158.2 150.3
Root-Mean-Square Deviations
Bond lengths (A˚) 0.002 0.002
Bond angles () 0.665 0.550
Molprobity Statistics
Ramachandran favored (%) 91.2 90.6
Allowed (%) 7.4 8.2
Outliers (%) 1.31 1.2
All-atom clash score 4.27 4.79
Overall score 1.72 2.01
Solvent content (%) 68.5 78.5
Molecules of V domain/
asymmetric unit
2 2
These crystallography statistics are given for an open conformation of the
human Alix V domain (PDB ID: 4JJY) and a crystal structure of the yeast
Bro1 V domain in a complex with Ub (PDB ID: 4JIO).
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Bro1 as a Ubiquitin-Sorting Receptorproduced at levels identical to those of full-length S. cerevisiae
Bro1-HA and complemented the MVB sorting defects (Fig-
ures 7A and S7). Two Ub-binding-defective mutants of Bro1
(Bro1DUBD1, I377R; and Bro1DUBD2, L386R) also complemented
bro1D mutants and were able to sort Ste3-GFP and Ste3-GFP-
Ub into the vacuole, although modest defects were observed
for Ste3-GFP sorting by the Bro1DUBD2 mutant. Their level of
expression was identical to WT Bro1-HA and not affected by
hse1D or vps27DChc1 mutations (Figure S7). These data demon-
strate that the Bro1 mutants retain their general folding and
function. We reasoned that if Bro1—and, in particular, the Ub-
binding capacity of Bro1—functions in parallel with ESCRT-0Develas a Ub-sorting receptor, then the functional defects of
Bro1DUBD1 and Bro1DUBD2 would be compensated for by
ESCRT-0. Thus, we analyzed the ability of Bro1DUBD1 and
Bro1DUBD2 to mediate MVB sorting in cells where ESCRT-0
was compromised by either loss of Hse1 or loss of clathrin bind-
ing to Vps27. Notably, hse1D mutants and vps27DChc1 mutants
have no phenotype on their own; also, double mutants with
bro1 (bro1D hse1D and bro1D vps27DChc1) were complemented
for MVB sorting by Bro1-HA with the WT V domain. In contrast,
sorting of Ste3-GFP was markedly defective when either of
the Bro1DUBD1 and Bro1DUBD2 alleles was combined with the
vps27DChc1 allele or loss of Hse1 (Figures 7B and 7C). Severe
sorting defects were also observed for Ste3-GFP-Ub. More
moderate defects were observed when Bro1DUBD1 and
Bro1DUBD2 combined with the vps27DChc1 allele, which may
reflect that loss of clathrin binding compromises ESCRT-0 func-
tion less than loss of Hse1. Both the Bro1DUBD1 and Bro1DUBD2
proteins were able to restore carboxypeptidase Y (CPY) sorting
to not only bro1D mutants but also the bro1D hse1D and bro1D
vps27DChc1 mutants, indicating that the deficiency caused by
loss of Ub binding was specific to MVB sorting and not to all
other Bro1 functions. In addition, we found that Bro1DUBD1 and
Bro1DUBD2 cells had a normal distribution of GFP-tagged Ub,
indicating that the Doa4DUbwas functioning normally to remove
Ub from MVB cargo late in the process of sorting.
DISCUSSION
Based on the data presented here and elsewhere, we propose
that Bro1 works early in the MVB biogenesis pathway, as a
Ub-sorting receptor that functions in parallel with ESCRT-0.
This role would be distinct from its later function as a recruitment
factor for Doa4, the DUb that works late in the process of MVB
biogenesis to recycle Ub from cargo postsorting (Amerik et al.,
2006; Richter et al., 2007). This model is supported by the
genetic interactions we observed between ESCRT-0 and Bro1,
wherein hypomorphicmutations in both showdramatic synthetic
phenotypes. Further support comes from the observation that
expressing Bro1-DUb fusion proteins blocks the sorting of cargo
into MVBs and from the finding that Bro1 shares several binding
partners with ESCRT-0, including Ub, clathrin, ESCRT-I, Ub
ligases, and DUbs (Nikko and Andre´, 2007). These interactions
provide a biochemical rationale for how Bro1 can execute an
ESCRT-0-like function as a Ub-sorting receptor. We found that
the interaction of the Bro1 V domain with Ub was critical for
sorting Ub-cargo into MVBs only when ESCRT-0 function was
weakened, an observation supporting the idea that Bro1 and
ESCRT-0 provide similar overlapping functions. Interestingly,
even when Ub-cargo sorting was blocked, other functions
such as sorting of the soluble vacuolar hydrolase CPY were
normal, demonstrating that the MVB and vacuolar hydrolase
sorting functions of Bro1 are separable and that Ub binding con-
tributes to the former.
Together, these data suggest that Bro1 belongs to an expand-
ing coterie of endosomal Ub-sorting receptors, thereby diversi-
fying membership beyond ESCRT-0, GGA, and Tom1-related
proteins, which have a very similar domain organization (Clague
et al., 2012; Shields and Piper, 2011). It is plausible that each of
these Ub receptors directs its attention to specific sets of cargosopmental Cell 25, 520–533, June 10, 2013 ª2013 Elsevier Inc. 527
Figure 4. Crystal Structure of the Bro1 V
Domain in Complex with Ub
(A) Structures (3.6 A˚) of the Bro1 V domains found
within the asymmetric unit (PDB ID: 4JIO). A
cartoonmodel of the Alix V domain (PDB ID: 2OEX)
is shown at right. Below is an alternate view from
the top of the arms, looking into the vertex of the
two Bro1 V domain structures together with Alix V.
The backbone is colored blue-to-red according to
amino acid order (N to C terminus). Loops not
resolved in electron density maps are represented
by dotted lines.
(B) Structure of the Ub:Bro1 V domain complex
showing Ub (green) bound to the N terminus of the
Bro1 V domain within the first trihelical bundle
(residues 370–392, indicated in blue). Model at
right is a closer view of Ub:V interaction. Ub resi-
dues that undergo significant NMR chemical
perturbation upon Bro1 V binding are shown in
red. Positions of the Bro1 V I377 and L386 Ca
atoms are shown in orange.
See also Figure S4 and Table S1.
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Bro1 as a Ubiquitin-Sorting Receptorwith some level of overlap. This possibility is supported by
our findings that loss of Bro1 or mutation of the Ub-binding
site in the V domain leads to more dramatic defects in MVB
sorting for cargos such as Ste3 than for others such as Mup1.
If Bro1 does work as an upstream Ub-sorting receptor in the
MVB biogenesis pathway, then the mammalian Bro1 family
members Alix and HD-PTP may likewise execute such a func-
tion. Correspondingly, Alix was found to bind membrane pro-
teins bearing YPxL motifs and to usher them into endosomal
ILVs (Baietti et al., 2012; Dores et al., 2012). For one of these
cargos (Par1), ubiquitination of the cargo itself was not required
(although ubiquitination of associated proteins might be), sug-
gesting that Alix can work as a sorting receptor for certain Ub-
independent cargos. Since the Alix V domain binds Ub, it is
possible that this protein also serves as a receptor for Ub-
cargos. Unlike the loss of ESCRT-0 or ESCRT-I, loss of Alix
in mammalian cells does not dramatically alter endosome528 Developmental Cell 25, 520–533, June 10, 2013 ª2013 Elsevier Inc.morphology, nor does it block sorting
of the few ubiquitinated membrane pro-
tein cargos that have been examined
(Odorizzi, 2006). Thus, Alix may handle
only a subset of Ub-cargos, or ESCRT-0
could substitute for Alix’s absence
in experimental contexts. Interestingly,
Dictyostelium discoideum does not have
a canonical ESCRT-0 (Hrs/STAM) but
does express a Bro1 homolog (Dd-Alix)
and a Tom1 homolog (Dd-Tom1), the
latter of which participates in many of
the same protein interactions as a canon-
ical ESCRT-0. Nevertheless, eliminating
Dd-Tom1 affects neither the sorting
of endosomal ubiquitinated proteins nor
the biogenesis of MVBs, suggesting that
Dd-Alix instead may provide much of
the ESCRT-0-like function in this organ-
ism (Blanc et al., 2009).Like both Alix and Bro1, HD-PTP also directly binds Ub,
ESCRT-I, and ESCRT-III and localizes to endosomes (Doyotte
et al., 2008; Miura et al., 2008; Nikko and Andre´, 2007; Stefani
et al., 2011; Strack et al., 2003). Loss of HD-PTP promotes cell
migration and is associated with cancer progression (Cao
et al., 1998; Castiglioni et al., 2007; Gilbert et al., 2011; Lin
et al., 2011). At the cellular level, RNA interference (RNAi)-medi-
ated depletion of HD-PTP causes morphological changes in
endosomes and an accumulation of ubiquitinated proteins on
them, a cellular phenotype similar to that resulting from
ESCRT-0 depletion (Doyotte et al., 2008). Although it is not clear
what types of Ub-cargo HD-PTP might sort, candidates include
EGFR, integrins, and E-cadherin (Castiglioni et al., 2007; Lin
et al., 2011; Miura et al., 2008).
Although we have speculated that other Bro1 family members
can behave as endosomal Ub-sorting receptors, their capacity
to bind Ub could instead be used for different or additional
CA
Ab-initio
Bro1 VAb-initio
ALIX V
C
ry
st
al
 s
tru
ct
ur
e 
A
LI
X
 V
 (6
.5
Å
)
S
A
X
S
Surface Cartoon
D
C
ry
st
al
 s
tru
ct
ur
e 
A
LI
X
 V
 (P
D
B
:2
O
E
X
)
B
Figure 5. Alix and Bro1 V Domains in the Open Conformation
(A and B) Ab initio envelopes of (A) human Alix V domain and (B) the S. castelli
Bro1 V domain, as determined by SAXS.
(C) Space-filling (left) and cartoon rendering (right) of the 6.5 A˚ crystal structure
of human Alix V domain in an alternative open conformation (PDB ID: 4JJY).
Experimental electron density contoured at 1s shown at left is shown as a gray
mesh at right.
(D) Left: molecular surface and cartoon overlay of Alix V (PDB ID: 2OEX) in the
closed conformation. Right: overlay of closed Alix V (colored) onto the open
conformation of Alix V (gray) (right).
See also Figure S5, Table S1, and Movie S1.
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Bro1 as a Ubiquitin-Sorting Receptorpurposes. For instance, many Ub-binding proteins, including
Alix, can themselves undergo ubiquitination and may act as a
scaffold for a variety of other Ub-binding proteins involved in
endocytosis and/or viral budding (Hoeller and Dikic, 2010; Sette
et al., 2010). In the future, such alternative models can be tested
using Ub-binding-defective mutants of other Bro1 family pro-
teins. Predicting how to generate suchmutantswill be somewhat
challenging, however. Although the Ub-binding region we identi-
fied is conserved among Bro1 orthologs, how to accurately pre-
dict the Ub-binding site in the V domains of other proteins is not
obvious. The V domains of HD-PTP, Alix, and Bro1 are only
13%–15% identical, and recent mutagenesis experiments indi-
cate that Alix houses a UBD somewhere within its distal trihelical
arm, along a sequence that is only conserved across Alix ortho-
logs (Dowlatshahi et al., 2012; Keren-Kaplan et al., 2013). This
theme of different Ub-binding modes between functional ortho-
logs is found for components of the ESCRT apparatus as well;DevelVps27 (ESCRT-0), Mvb12 (ESCRT-I), and Vps36 (ESCRT-II)
share the ability to bind Ub with their mammalian counterparts
Hrs, Mvb12A, UBAP1, and Eap45 but use different binding
motifs to do so (Clague et al., 2012; Shields and Piper, 2011).
This is consistent with the fact that low-affinity binding motifs
for Ub are often structurally simple, suggesting they may not
be that challenging to evolve.
EXPERIMENTAL PROCEDURES
Plasmids and yeast strains used are listed in Tables S1 and S2. BRO1-
expressing plasmids with various V domains were made in low-copy/yeast
centromere plasmids encoding the BRO1 promoter and the flanking N-termi-
nal and C-terminal portions of S. cerevisiaeBro1 upstream of twoHA epitopes.
V domains produced in E.coli BL21(DE3) were purified over TALON-Co2+
and size exclusion chromatography and cleaved from their 6XHis tag with
TEV protease prior to crystallography. Selenomethionine (SeMet)-labeled
proteins were expressed using the methionine pathway inhibition procedure
(Doublie and Carter, 1992).
Diffraction data were collected on the 4.2.2 beamline at the Advanced Light
Source (Berkeley, CA, USA) on crystals containing Ub (A28M to allow labeling
with selenium) and Bro1 V (with K417A, K418A, K419A mutations made to
reduce surface entropy; Goldschmidt et al., 2007) or crystals of Alix. Data for
SeMet-Bro1V:Ub (A28M) were processed using d*TREK (Pflugrath, 1999)
and phased with phenix.autosol (Terwilliger et al., 2009) using the single-wave-
length anomalous dispersion method. Phenix.autobuild and phenix.refine
were used to iteratively build and improve the Bro1V Ca-only model. Ub
(Protein Data Bank [PDB] ID: 1UBQ) was docked into the clearly visible density
near the Bro1V N terminus and refined with all atoms. The diffraction data for
SeMet-AlixV:Ub were integrated and scaled using d*TREK and prepared for
SHELXD (Sheldrick, 2008) using xprep (Bruker AXS, Madison, WI, USA).
Phenix was used to improve the quality of the map sufficiently so that the
two arms of AlixV from the high-resolution structures could be independently
placed in the electron density and then refined with secondary structure re-
straints in place. Coot was used to manually fit the structure, and PyMOL
was used to generate the structural figures.
SAXS data (collected at the 12-ID-B beamline at the Advanced Photon
Source, Argonne National Laboratory, Argonne, IL, USA; and the SIBYLS
12.3.1 beamline at the Advanced Light Source, Lawrence Berkeley National
Laboratory, Berkeley, CA, USA) were processed with PRIMUS (Konarev
et al., 2003). The radius of gyration (Rg) estimated from Guinier plots was
34.3 A˚ for Alix V and 35.4 A˚ for Bro1 V. The maximum diameter (Dmax) deter-
mined with GNOM was 116.0 A˚ and 111.1 A˚ for Alix and Bro1 V domains,
respectively. The ab initio models were generated with GASBOR (Svergun
et al., 2001). FoXS, along with its Minimal Ensemble Search algorithm, was
used to calculate weighted fit of the open and closed forms of V domains
(Schneidman-Duhovny et al., 2010).
15N-HSQCdata were collected at 25Con aBruker Avance II 800MHz spec-
trometer and analyzed with SPARKY (T.D. Goddard and D.G. Kneller, SPARKY
3, University of California, San Francisco, San Francisco, CA, USA) and
NMRView (One Moon Scientific, Westfield, NJ, USA). Chemical shift perturba-
tions were measured by comparing peak positions to 15N-Ub alone using
(0.2*DppmN2 + DppmH2)1/2). Paramagnetic relaxation enhancement effects
were measured using cysteine-containing Bro1 proteins labeled with MTSL
[(1-oxyl-2,2,5,5-tetramethylpyrroline-3-methyl)-methanethiosulfonate] (Tor-
onto Research Chemicals, Toronto, Ontario, Canada). Incorporation to
>90%was validated by electron spin resonance analysis. Peak intensity ratios
of 15N-Ub when bound to the oxidized versus reduced MTSL-labeled Bro1
proteins were calculated to quantify the degree of PRE effects.
GFP-fusion proteins were localized in cells grown to mid-log phase at 30C
and imaged as previously described (Bilodeau et al., 2003). Genes under
control of the CUP1 promoter were induced with 50 mM CuCl2. Yeast protein
extracts for immunoblotting were prepared as described elsewhere (Kush-
nirov, 2000). GST pull-down experiments and immunoprecipitations were
done as described previously (Bilodeau et al., 2003; Pashkova et al., 2010).
Binding to K63 poly-Ub was done by attaching recombinant 6xHis-V5-tagged
V domains to 30 ml of beads coated with polyclonal anti-V5 antibodies, whichopmental Cell 25, 520–533, June 10, 2013 ª2013 Elsevier Inc. 529
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Figure 6. Mutagenesis of the Ub-Binding Region of Bro1 V Domain
(A) The indicated mutations were made in the context of the S. castelli Bro1 domain, which contains a cysteine residue at position 381. These proteins were
labeled with MTSL and used in PRE experiments with 15N-Ub at a Brol V:Ub ratio of 3:1. Peak intensity ratios (oxidized versus reduced spin label) for each Ub
residue were calculated from HSQC spectra collected in the absence and presence of 2 mM ascorbate. The degree of PRE effect experienced by each Ub
backbone amide is color coded as indicated.
(B) Index of chemical-shift perturbations in 15N-Ub upon binding to mutant Bro1 V domains. Chemical shift perturbation (CSP) index was calculated by summing
the (0.2DN2 + DH2)1/2 values for Ub residues 8, 42, 44, 48, 49, 69, 70, and 71 and setting that value equal to 1 for the WT Bro1 V domain.
(C) The WT and mutant recombinant V domains were immobilized on a-V5 polyclonal antibody-coated beads, washed, and incubated with K63-linked poly-
ubiquitin chains. Beads alone or bound to an irrelevant V5-epitoped protein were also included. Beads were washed and immunoblotted with a-V5 or a-Ub
monoclonal antibodies.
See also Figure S6 and Table S1.
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Figure 7. MVB Sorting Requires Bro1 to
Bind Ub
(A) Null mutant bro1D cells were transformed with
low-copy-number plasmids expressing a WT
chimeric Bro1 with the V domain from S. castelli
Bro1, with or without mutations in the Ub-binding
region of the V domain. The bro1DUBD1 allele
carries the I377R mutation; bro1DUBD2 carries the
L386R mutation. Cells also expressed Ste3-GFP
(left) or Ste3-GFP-Ub (right). Shown are GFP
fluorescence and DIC images.
(B) Same as in (A), but bro1D cells also carried the
vps27DChc1 allele that blocks the ability of Vps27 to
bind directly to clathrin.
(C) Same as in (A) but bro1D cells also lack the
ESCRT-0 subunit Hse1. Scale bar, 5mm.
See also Figure S7 and Tables S1 and S2.
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Bro1 as a Ubiquitin-Sorting Receptorwere subsequently incubated for 1 hr with 2 mg of K63-linked poly-Ub (Boston
Biochemicals, Cambridge, MA, USA) in 200 ml PBS containing 0.02% of Triton
X-100, 0.1% bovine serum albumin or casein. Beads were washed five times;
bound complexes were eluted with Laemmli sample buffer and heating to
70C for 5 min.
To compare yeast genomic DNA, 7–9 million 75-base-pair, single-end reads
were generated for each sample on a HiSeq 2000 platform machine (Illumina,
San Diego, CA, USA). Data were analyzed by the University of Washington
Genome Sciences group as detailed in the Supplemental Experimental
Procedures.
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The structures of the Bro1 V:Ub complex and an open conformation of Alix V
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